The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
BackgroundSugammadex is a novel neuromuscular reversal agent, but its associated hypersensitivity reaction and high cost have been obstacles to its widespread use. In the interest of reducing the necessary dosage of sugammadex, the reversal time of the combined use of sugammadex and neostigmine from...
Main Authors: | Soon Ho Cheong, Seunghee Ki, Jiyong Lee, Jeong Han Lee, Myoung-Hun Kim, Dongki Hur, Kwangrae Cho, Se Hun Lim, Kun Moo Lee, Young-Jae Kim, Wonjin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2015-12-01
|
Series: | Korean Journal of Anesthesiology |
Subjects: | |
Online Access: | http://ekja.org/upload/pdf/kjae-68-547.pdf |
Similar Items
-
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01) -
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01) -
Initial experience with the unrestricted introduction of sugammadex at a large academic medical center: a retrospective observational study examining postoperative mechanical ventilation and efficiency outcomes
by: Vikas N. O’Reilly-Shah, et al.
Published: (2018-10-01) -
Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
by: Abdulhamid Alsaeed, et al.
Published: (2017-01-01) -
An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
by: Stephania Paredes, et al.
Published: (2023-03-01)